Modelling of the blood-brain barrier in drug discovery and development

Abstract : The market for neuropharmaceuticals is potentially one of the largest sectors of the global pharmaceutical market owing to the increase in average life expectancy and the fact that many neurological disorders have been largely refractory to pharmacotherapy. The brain is a delicate organ that can efficiently protect itself from harmful compounds and precisely regulate its microenvironment. Unfortunately, the same mechanisms can also prove to be formidable hurdles in drug development. An improved understanding of the regulatory interfaces that exist between blood and brain may provide novel and more effective strategies to treat neurological disorders.
Type de document :
Article dans une revue
Nature Reviews Drug Discovery, Nature Publishing Group, 2007, 6, p. 650-661
Liste complète des métadonnées

https://hal-univ-artois.archives-ouvertes.fr/hal-00543630
Contributeur : Wilfried Déplanques <>
Soumis le : lundi 6 décembre 2010 - 14:15:44
Dernière modification le : lundi 6 décembre 2010 - 14:15:44

Identifiants

  • HAL Id : hal-00543630, version 1

Collections

Citation

Roméo Cecchelli, Vincent Berezowski, Stefan Lundquist, Maxime Culot, Mila Renftel, et al.. Modelling of the blood-brain barrier in drug discovery and development. Nature Reviews Drug Discovery, Nature Publishing Group, 2007, 6, p. 650-661. 〈hal-00543630〉

Partager

Métriques

Consultations de la notice

41